Finally, although the implication of group X (sPLA2‐X) in metabolic diseases is still uncertain (Sato et al., 2016), sPLA2‐X activity was associated with suppression of insulin secretion in mice (Shridas et al., 2014). Here, INS is linked to metabolic disease.